Trial intelligence / Profile preview

Valdecoxib for acute pain after ACL reconstruction

NCT00650039Phase 3Completed

Sponsor
Pfizer
Start
Mar 2004
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of valdecoxib in Acute postsurgical pain (APSP), sponsored by Pfizer. Started Mar 2004; status: completed.

02

Drugs

valdecoxib
03

Conditions

Acute postsurgical pain (APSP)

Beyond the preview

Go deeper on NCT00650039.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00650039.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call